Research Article
High SHIP2 Expression Indicates Poor Survival in Colorectal Cancer
Table 2
Univariate and multivariate analyses of prognostic factors in 102 CRC patients for overall survival.
| | Univariate analysis | Multivariate analysis | | HR | | 95% CI | HR | | 95% CI |
| SHIP2 expression | | | | | | | High versus low | 2.20 | 0.017* | 1.151–4.189 | 2.05 | 0.040* | 1.031–3.820 | Gender | | | | | | | Male versus female | 1.44 | 0.281 | 0.744–2.774 | | | | Age (years) | | | | | | | ≥60 versus <60 | 0.83 | 0.562 | 0.439–1.565 | | | | Tumor size (cm) | | | | | | | ≥5 versus <5 | 1.29 | 0.410 | 0.701–2.388 | | | | Tumor location | | | | | | | Colon versus rectum versus ileocecal junction | 0.68 | 0.354 | 0.306–1.528 | | | | Histological type | | | | | | | Adenocarcinoma versus nonadenocarcinoma | 1.05 | 0.960 | 0.145–7.662 | | | | Tumor differentiation | | | | | | | Well and moderately versus poorly | 1.50 | 0.413 | 0.569–3.943 | | | | Serum CEA level (ng/mL) | | | | | | | ≥15 versus <15 | 2.33 | 0.057 | 0.976–5.573 | | | | Lymph node metastasis | | | | | | | Positive versus negative | 2.91 | 0.001* | 1.573–5.408 | 1.26 | 0.668 | 0.443–3.568 | Distant metastasis | | | | | | | Positive versus negative | 7.06 | 0.001* | 3.687–13.521 | 5.09 | 0.001* | 2.034–12.736 | TNM stage | | | | | | | Stages I-II versus stages III-IV | 0.25 | 0.001* | 0.129–0.466 | 0.72 | 0.638 | 0.188–2.789 |
|
|
.
|